Dr. Robert A. Skidmore Jr., MD

Dr. Skidmore practices at Florida Skin Cancer & Dermatology Specialists, PA in Gainesville, Florida.

Dr. Skidmore's NPI, 1245322049, was assigned on September 29, 2006. Dr. Skidmore graduated from University Of Florida College Of Medicine in 1989. Dr. Skidmore holds Florida license ME59336.

Dr. Skidmore's primary practice is Florida Skin Cancer & Dermatology Specialists, PA, at 3700 Nw 83rd St, Gainesville, FL 32606-5603. The practice phone is (352) 371-7546.

Dr. Skidmore's primary practice is Florida Skin Cancer & Dermatology Specialists, PA in Gainesville, Florida. The medical group on file is Florida Skin Cancer & Dermatology Specialists. Dmand AI also links Dr. Skidmore to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Skidmore practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Skidmore's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Skidmore is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Skidmore's licenses on file in 3 states: Florida, Georgia and North Carolina.

CMS data shows 9,279 Medicare services from Dr. Skidmore across 35 procedure codes in 2024, for 1,924 Medicare patients. Medicare paid $704,167 for them. Every service was in an office.

CMS counts 1,924 Medicare patients who saw Dr. Skidmore in 2024. The largest group is 75 to 84, with 863 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Skidmore's median patient age at 74, with 52% women.

In 2024, Dr. Skidmore wrote 495 Medicare Part D claims for 338 patients. 100% of them were for generic drugs. CMS names the drug for 457 of them, across 10 drugs with 11 or more claims each, at $4,932 in total drug cost. In 2023, CMS named 622 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Skidmore for performance year 2024, reported individually. Dr. Skidmore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,630 procedures of removal of skin lesions by Dr. Skidmore, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Skidmore. The most frequent topics are Diagnosis, Differential, Skin and Skin Diseases. Dr. Skidmore has published most often in Arch Dermatol. Dr. Skidmore's most frequent co-authors are Isaac M. Neuhaus, MD and Robert S. Tomsick, MD.

CMS Open Payments shows 1 general payment to Dr. Skidmore from 1 drug or device company in 2022. Education make up the largest share, 100% of the total. Pfizer Inc. paid the most, $30.

Dr. Skidmore graduated from University Of Florida College Of Medicine in 1989.

Dr. Skidmore is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.